The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Company profile

BridgeBio Pharma, Inc. insider acquisitions

Company CIK 0001743881 · Reported insider acquisitions and filing context.

Company filings at SEC ↗
BBIO · Nasdaq

These are company listings. A transaction is linked to a particular security only when the filing provides enough information.

Company activity summary

By transaction date, as of October 23, 2026.

7 days30 days90 daysOverlapping periods · securities and currencies kept separate

No records are loaded for this 7-day transaction window. This does not establish that no transactions occurred.

Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Kumar NeilKumar NeilScott Randal W.Scott Randal W.Valantine HannahValantine HannahDANIELS RONALD JDANIELS RONALD JKumar Neil · December 12, 2025 · Exercise / conversion · Common StockScott Randal W. · November 17, 2025 · Exercise / conversion · Common StockKumar Neil · November 16, 2025 · Exercise / conversion · Common StockKumar Neil · November 16, 2025 · Exercise / conversion · Common StockKumar Neil · November 16, 2025 · Exercise / conversion · Common StockValantine Hannah · November 12, 2025 · Exercise / conversion · Common StockDANIELS RONALD J · November 6, 2025 · Exercise / conversion · Common StockNov 6, 2025Dec 12, 2025
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

7 dated transactions · 4 of 4 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Dec 12, 2025BridgeBio Pharma, Inc.Common StockKumar NeilExercise / conversion
Nov 17, 2025BridgeBio Pharma, Inc.Common StockScott Randal W.Exercise / conversion
Nov 16, 2025BridgeBio Pharma, Inc.Common StockKumar NeilExercise / conversion
Nov 16, 2025BridgeBio Pharma, Inc.Common StockKumar NeilExercise / conversion
Nov 16, 2025BridgeBio Pharma, Inc.Common StockKumar NeilExercise / conversion
Nov 12, 2025BridgeBio Pharma, Inc.Common StockValantine HannahExercise / conversion
Nov 6, 2025BridgeBio Pharma, Inc.Common StockDANIELS RONALD JExercise / conversion

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Share price & reported acquisitions

Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.

Price history is not available

Market-price history is not connected yet.

BBIO · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.

Reported acquisitions

Filing-date filters apply to the list and timeline. The summary above uses transaction dates.

Reset
Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedReporting ownersType / securityQuantityPrice / reference valueDetails
Trade:
Kumar NeilChief Executive Officer · Director
Exercise / conversionCommon StockNon-derivative security · Code M60,975Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Exercise / conversionCommon StockNon-derivative security · Code M10,00016.75Value: 167,500Currency not specifiedView ↗
Trade:
Kumar NeilChief Executive Officer · Director
Exercise / conversionCommon StockNon-derivative security · Code M11,554Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade:
Kumar NeilChief Executive Officer · Director
Exercise / conversionCommon StockNon-derivative security · Code M19,599Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade:
Kumar NeilChief Executive Officer · Director
Exercise / conversionCommon StockNon-derivative security · Code M33,544Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Exercise / conversionCommon StockNon-derivative security · Code M25,48448.45Value: 1,234,699.8Currency not specifiedView ↗
Trade: Exercise / conversionCommon StockNon-derivative security · Code M61,03134.65Value: 2,114,724.15Currency not specifiedView ↗

Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →